238 related articles for article (PubMed ID: 25293948)
21. CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.
Pal-Ghosh R; Xue D; Warburton R; Hill N; Polgar P; Wilson JL
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203295
[TBL] [Abstract][Full Text] [Related]
22. Designed inhibitor for nuclear localization signal of polo-like kinase 1 induces mitotic arrest.
Chen F; Zhuo X; Qin T; Guo X; Zhang C; Lai L
Chem Biol Drug Des; 2017 May; 89(5):732-740. PubMed ID: 27882722
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
Tsvetkov L; Stern DF
Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
[TBL] [Abstract][Full Text] [Related]
24. The Plk1-dependent phosphoproteome of the early mitotic spindle.
Santamaria A; Wang B; Elowe S; Malik R; Zhang F; Bauer M; Schmidt A; Silljé HH; Körner R; Nigg EA
Mol Cell Proteomics; 2011 Jan; 10(1):M110.004457. PubMed ID: 20860994
[TBL] [Abstract][Full Text] [Related]
25. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
[TBL] [Abstract][Full Text] [Related]
26. Testicular phosphoproteome in perfluorododecanoic acid-exposed rats.
Shi Z; Hou J; Guo X; Zhang H; Yang F; Dai J
Toxicol Lett; 2013 Aug; 221(2):91-101. PubMed ID: 23800682
[TBL] [Abstract][Full Text] [Related]
27. Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.
Yang Q; Chen LS; Neelapu SS; Miranda RN; Medeiros LJ; Gandhi V
Blood; 2012 Oct; 120(17):3491-500. PubMed ID: 22955922
[TBL] [Abstract][Full Text] [Related]
28. The Functional Significance of Posttranslational Modifications on Polo-Like Kinase 1 Revealed by Chemical Genetic Complementation.
Lasek AL; McPherson BM; Trueman NG; Burkard ME
PLoS One; 2016; 11(2):e0150225. PubMed ID: 26919439
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
30. Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.
Kettenbach AN; Schweppe DK; Faherty BK; Pechenick D; Pletnev AA; Gerber SA
Sci Signal; 2011 Jun; 4(179):rs5. PubMed ID: 21712546
[TBL] [Abstract][Full Text] [Related]
31. Cell division cycle 6, a mitotic substrate of polo-like kinase 1, regulates chromosomal segregation mediated by cyclin-dependent kinase 1 and separase.
Yim H; Erikson RL
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19742-7. PubMed ID: 21041660
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions.
Lee KH; Hwang JA; Kim SO; Kim JH; Shin SC; Kim EE; Lee KS; Rhee K; Jeon BH; Bang JK; Cha-Molstad H; Soung NK; Jang JH; Ko SK; Lee HG; Ahn JS; Kwon YT; Kim BY
J Biol Chem; 2018 Jan; 293(3):847-862. PubMed ID: 29191835
[TBL] [Abstract][Full Text] [Related]
33. Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
Wang Y; Wu L; Yao Y; Lu G; Xu L; Zhou J
Cancer Lett; 2018 Nov; 436():1-9. PubMed ID: 30118839
[TBL] [Abstract][Full Text] [Related]
34. Testis-specific mak protein kinase is expressed specifically in the meiotic phase in spermatogenesis and is associated with a 210-kilodalton cellular phosphoprotein.
Jinno A; Tanaka K; Matsushime H; Haneji T; Shibuya M
Mol Cell Biol; 1993 Jul; 13(7):4146-56. PubMed ID: 8321219
[TBL] [Abstract][Full Text] [Related]
35. Polo-like kinase 1 inhibits DNA damage response during mitosis.
Benada J; Burdová K; Lidak T; von Morgen P; Macurek L
Cell Cycle; 2015; 14(2):219-31. PubMed ID: 25607646
[TBL] [Abstract][Full Text] [Related]
36. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis.
Nihal M; Stutz N; Schmit T; Ahmad N; Wood GS
Cell Cycle; 2011 Apr; 10(8):1303-11. PubMed ID: 21436619
[TBL] [Abstract][Full Text] [Related]
37. Global assessment of its network dynamics reveals that the kinase Plk1 inhibits the phosphatase PP6 to promote Aurora A activity.
Kettenbach AN; Schlosser KA; Lyons SP; Nasa I; Gui J; Adamo ME; Gerber SA
Sci Signal; 2018 May; 11(530):. PubMed ID: 29764989
[TBL] [Abstract][Full Text] [Related]
38. Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death.
O'Donovan DS; MacFhearraigh S; Whitfield J; Swigart LB; Evan GI; Mc Gee MM
Cell Death Dis; 2013 Jan; 4(1):e468. PubMed ID: 23348582
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.
Jang YJ; Ji JH; Choi YC; Ryu CJ; Ko SY
J Biol Chem; 2007 Jan; 282(4):2473-82. PubMed ID: 17121863
[TBL] [Abstract][Full Text] [Related]
40. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint.
van Vugt MA; Gardino AK; Linding R; Ostheimer GJ; Reinhardt HC; Ong SE; Tan CS; Miao H; Keezer SM; Li J; Pawson T; Lewis TA; Carr SA; Smerdon SJ; Brummelkamp TR; Yaffe MB
PLoS Biol; 2010 Jan; 8(1):e1000287. PubMed ID: 20126263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
